title: Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
abstract: (1) Medicare beneficiaries value the expansion of stand-alone prescription drug plans more than they value the expansion of HMOs. (2) The addition of subsidized stand-alone prescription drug plans generates nine times as much value per government dollar as the increase in payments to HMOs.
authors.affiliation: Changes in Health Care Financing & Organization, AcademyHealth, USA. bonnie.austin@academyhealth.org.
authors.forename: Bonnie J
authors.initials: BJ
authors.lastname: Austin
mesh_terms: D005102:Health Expenditures; D006279:Health Maintenance Organizations / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics* / Q000331:legislation & jurisprudence; D006278:Medicare / Q000191:economics* / Q000331:legislation & jurisprudence; D014481:United States